178 related articles for article (PubMed ID: 34315490)
1. MINDY1 promotes bladder cancer progression by stabilizing YAP.
Luo Y; Zhou J; Tang J; Zhou F; He Z; Liu T; Liu T
Cancer Cell Int; 2021 Jul; 21(1):395. PubMed ID: 34315490
[TBL] [Abstract][Full Text] [Related]
2. ATXN3 promotes prostate cancer progression by stabilizing YAP.
Wu L; Ou Z; Liu P; Zhao C; Tong S; Wang R; Li Y; Yuan J; Chen M; Fan B; Zu X; Wang Y; Tang J
Cell Commun Signal; 2023 Jun; 21(1):152. PubMed ID: 37349820
[TBL] [Abstract][Full Text] [Related]
3. USP26 promotes anaplastic thyroid cancer progression by stabilizing TAZ.
Tang J; Luo Y; Xiao L
Cell Death Dis; 2022 Apr; 13(4):326. PubMed ID: 35397626
[TBL] [Abstract][Full Text] [Related]
4. SOX13/TRIM11/YAP axis promotes the proliferation, migration and chemoresistance of anaplastic thyroid cancer.
Tang J; Tian Z; Liao X; Wu G
Int J Biol Sci; 2021; 17(2):417-429. PubMed ID: 33613102
[TBL] [Abstract][Full Text] [Related]
5. MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α.
Tang J; Luo Y; Long G; Zhou L
Cell Death Dis; 2021 Oct; 12(10):937. PubMed ID: 34645792
[TBL] [Abstract][Full Text] [Related]
6. RNF181 modulates Hippo signaling and triple negative breast cancer progression.
Zhou R; Ding Y; Xue M; Xiong B; Zhuang T
Cancer Cell Int; 2020; 20():291. PubMed ID: 32655323
[TBL] [Abstract][Full Text] [Related]
7. The deubiquitinating enzyme UCHL3 promotes anaplastic thyroid cancer progression and metastasis through Hippo signaling pathway.
Tang J; Yang Q; Mao C; Xiao D; Liu S; Xiao L; Zhou L; Wu G; Tao Y
Cell Death Differ; 2023 May; 30(5):1247-1259. PubMed ID: 36813921
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
9. The deubiquitinating enzyme USP19 facilitates hepatocellular carcinoma progression through stabilizing YAP.
Tian Z; Xu C; He W; Lin Z; Zhang W; Tao K; Ding R; Zhang X; Dou K
Cancer Lett; 2023 Nov; 577():216439. PubMed ID: 37832781
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Hippo signaling and triple negative breast cancer progression by an ubiquitin ligase RNF187.
Wang Z; Kong Q; Su P; Duan M; Xue M; Li X; Tang J; Gao Z; Wang B; Li Z; Liu Y; Yang X; Cao R; Song T; Wang K; Cai Y; Wu D; Li J; Wu G; Guled AM; Zhu J; Yan C; Zhuang T
Oncogenesis; 2020 Mar; 9(3):36. PubMed ID: 32198343
[TBL] [Abstract][Full Text] [Related]
11. SHARPIN Inhibits Esophageal Squamous Cell Carcinoma Progression by Modulating Hippo Signaling.
Zhang A; Wang W; Chen Z; Pang D; Zhou X; Lu K; Hou J; Wang S; Gao C; Lv B; Yan Z; Chen Z; Zhu J; Wang L; Zhuang T; Li X
Neoplasia; 2020 Feb; 22(2):76-85. PubMed ID: 31884247
[TBL] [Abstract][Full Text] [Related]
12. RASSF1A-Hippo pathway link in patients with urothelial carcinoma of bladder: plausible therapeutic target.
Khandelwal M; Anand V; Appunni S; Seth A; Singh P; Mathur S; Sharma A
Mol Cell Biochem; 2020 Jan; 464(1-2):51-63. PubMed ID: 31754973
[TBL] [Abstract][Full Text] [Related]
13. [Deubiquitinating enzyme MINDY1 is an independent risk factor for the maintenance of stemness and poor prognosis in liver cancer cells].
Xia BL; Liu KW; Huang HX; Shen MM; Wang B; Gao J
Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):518-523. PubMed ID: 37365029
[No Abstract] [Full Text] [Related]
14. Quantitative Real-Time PCR to Measure YAP/TAZ Activity in Human Cells.
Cao X; Zhao B
Methods Mol Biol; 2019; 1893():137-152. PubMed ID: 30565132
[TBL] [Abstract][Full Text] [Related]
15. Blockage of glioma cell survival by truncated TEAD-binding domain of YAP.
Zhao W; Dong QF; Li LW; Yan ZF; Huo JL; Chen XY; Yang X; Li PQ; Fei Z; Zhen HN
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1713-1723. PubMed ID: 33651140
[TBL] [Abstract][Full Text] [Related]
16. USP12 facilitates gastric cancer progression via stabilizing YAP.
Zhang P; Liu D; Zang Y; Wang J; Liu Z; Zhu J; Li X; Ding Y
Cell Death Discov; 2024 Apr; 10(1):174. PubMed ID: 38605077
[TBL] [Abstract][Full Text] [Related]
17. SKP2 and OTUD1 govern non-proteolytic ubiquitination of YAP that promotes YAP nuclear localization and activity.
Yao F; Xiao Z; Sun Y; Ma L
Cell Stress; 2018 Aug; 2(9):233-235. PubMed ID: 31225491
[TBL] [Abstract][Full Text] [Related]
18. USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ.
Zhu H; Yan F; Yuan T; Qian M; Zhou T; Dai X; Cao J; Ying M; Dong X; He Q; Yang B
Cancer Res; 2020 Jun; 80(11):2204-2216. PubMed ID: 32217697
[TBL] [Abstract][Full Text] [Related]
19. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
20. Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells.
Cucci MA; Compagnone A; Daga M; Grattarola M; Ullio C; Roetto A; Palmieri A; Rosa AC; Argenziano M; Cavalli R; Simile MM; Pascale RM; Dianzani C; Barrera G; Pizzimenti S
Free Radic Biol Med; 2019 Sep; 141():205-219. PubMed ID: 31207288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
